Synopsis: Once a market favourite, Jyothy Labs has corrected nearly 60% from its peak amid slowing earnings growth, margin pressures and weakening investor sentiment. The subsequent loss of the Pril and Fa licences added another challenge. Can the company’s diversified portfolio, debt-free balance sheet and Exo-led strategy drive a long-term turnaround?
Jyothy Labs was once among the market’s favourite FMCG stocks, backed by strong brands, consistent earnings growth and a debt-free balance sheet. However, the stock has corrected nearly 60% from its peak as slowing earnings, margin pressures and valuation concerns weighed on investor sentiment.
The later announcement regarding the loss of the Pril and Fa licences further intensified uncertainty. With a diversified brand portfolio, strong financial position and renewed focus on Exo, investors are now watching whether the company can revive its growth trajectory. With a market cap of Rs 7,000 crore, the shares of Jyothy Labs Ltd are trading at Rs 190 and are trading at a PE of 22 compared to their industry’s PE of 26.
Once a Market Favourite, Now Facing Its Biggest Test
Previously considered among the most favoured FMCG stocks in the market, Jyothy Labs has gained its popularity owing to popular household brand names like Ujala, Exo, Henko, Maxo, Margo, and Pril.
The company’s growing earnings, rising margins, asset-light operations, and absence of debt have ensured that the stock has performed as a good wealth creator for many years now, reaching its all-time high level of around Rs 593 in late 2024.
However, the sentiment surrounding the stock has completely shifted since then. The stock has declined by around 60% from its highs, with concerns prevailing about reduced earnings and margin pressure along with the loss of two major brands, Pril and Fa
Although the fall in the stock price has been substantial, the fundamentals of Jyothy Labs remain sound enough. While the market has mostly been concerned about the loss of Pril, Jyothy still has other popular household brand names in categories like fabric care, dishwash, household insecticides, and personal care. It will thus be seen how well the management will be able to make up for the losses in revenue and revive growth.
A Decade of Consistent Financial Execution
Operating in a highly competitive FMCG segment of India’s market economy, Jyothy Labs has managed to establish itself as a financially successful entity during a period of a decade. In particular, Jyothy Labs demonstrated its capability to steadily increase the income level due to the product mix enhancement, tight control of costs and operational effectiveness.
Over the period from FY20 to FY26, consolidated sales revenues went up from Rs 1,711 crore to Rs 2,847 crore. The company’s net profit jumped from Rs 163 crore to Rs 370 crore. Margins have also seen a significant improvement during the reporting period. In particular, the OPM margin has grown from 15% in FY20 to 18% in FY25.
Even during FY26, which turned out to be a challenging year for the FMCG sector, Jyothy Labs managed to deliver 3.4% revenue growth, supported by nearly 6% volume growth, although profitability came under pressure because of lower realisations and inflation in raw material costs.
EBITDA declined by around 10% to Rs 450 crore while adjusted PAT fell about 11% to Rs 333 crore. Nevertheless, the company remained debt-free with approximately Rs 1,000 crore of cash, giving it significant financial flexibility for future expansion and acquisitions.
The Biggest Blow: Losing Pril and Fa
Investor sentiments changed with the announcement in June 2026 of non-renewal of licensing agreements between Henkel and Jyothy Labs for the Pril and Fa brands. This decision, made by Henkel after more than fourteen years of collaboration, led to the discontinuation of manufacturing, marketing, selling, and distributing both brands from June 2026 onwards, along with commencing arbitration proceedings at the Singapore International Arbitration Centre.
While the Pril brand constituted a modest share of only 7-8% in terms of annual sales of Jyothy Labs and generated almost Rs 225-240 crore in revenue, it had become the premium dishwashing liquid brand of Jyothy Labs. It was acknowledged that this would be a temporary setback for the company in FY27, which will have to face margin pressure due to this.
However, management also clarified that Fa was of only minimal importance to the business, and there won’t be any material impact of this on the fundamentals of the company. But investors were concerned about how easy it would be to replace a premium brand product with another one, especially in an extremely competitive category like dishwashing liquids.
Management Bets on Exo for the Next Growth Phase
Rather than acquiring another international brand or developing a new product range, Jyothy Labs has chosen the path of enhancing Exo as its key dishwashing brand. As per management, the Exo Liquid was there in the brand portfolio from 2005 to 06 but did not get adequate attention post the Pril acquisition in 2011. In future, Exo will emerge as the key brand for dishwashing bars as well as liquids, making it easier for the company to capitalize on its existing brand and its wide distribution network.
Management also feels that Exo has certain structural benefits. First, the brand already has a strong presence across India, strong relationships with distributors, and is leading in the dishwash bar category. More significantly, the newly launched Exo Liquid, based on bio-enzymes, is a differentiating factor for the brand, which comes at a competitive price point compared to market leaders. Unlike its competitors, Exo does not target only the premium segment.
Alongside Exo, the company has confirmed that multiple new product developments (NPDs) are under development across categories. These launches are expected to partially bridge the revenue gap created by Pril’s exit while opening fresh growth opportunities beyond the dishwashing segment. Management also reiterated that it continues to evaluate inorganic growth opportunities, although it emphasized that acquisitions will only be pursued if they are strategically attractive and create long-term shareholder value.
A Diversified Portfolio Reduces the OverallRisk
Despite this development being negative for the company, the business of Jyothy Labs is highly diversified beyond just being a brand story. The company has managed to create brands in areas such as fabric care, dishwash, household insecticides, home care and personal care, which has limited the exposure of the company to a single product.
For instance, fabric care and personal care in FY26 saw solid double-digit growth, while home insecticides also managed to see further recovery. The management plans to close the revenue gap by building Exo and growing the business by launching more products and not limiting itself to dishwashing liquids alone.
Financial Strength Gives Management Flexibility
The second major advantage of Jyothy Labs is the strength of the company’s balance sheet. It is completely debt-free and has more than Rs 1,000 crore worth of cash and investments, which will give it plenty of room to invest in brands, advertising, and new product launches or acquisitions without stressing itself financially.
The management says that they have been looking for potential acquisitions and will be prudent when making decisions. This strong financial position also means that the company can aggressively support the Exo brand and others during FY27 despite having lower margins temporarily because of the transition period.
Why Has the Stock Fallen So Sharply?
The correction in the stock price of Jyothy Labs was mainly on account of the fact that Henkel had announced that it would not be renewing the licences for the Pril and Fa brands beyond May 2026. Given the fact that Pril accounted for around 7-8% of revenues and also held a good market position in premium dishwash liquid, investors quickly discounted the reduced profitability levels.
Furthermore, higher input prices along with reduced margins and slowing profit growth compounded the issues. The brokerages too have scaled down their forecasts; however, a number of analysts feel that the long-term fundamentals still hold due to the diversification and financial strength of the company.
What Should Investors Watch Going Forward?
The most important monitorable will be how effectively Jyothy Labs manages to scale up Exo Dishwash Liquid as an alternative for the Pril business. According to management, the Exo dishwash liquid has a national distribution channel and brand equity in bars and has generated positive market reaction in its re-launch as a liquid product.
The other aspects which should be monitored include the rate of product launches, improvement of margins through increased pricing, performance of the home insecticide business and any acquisition done by the company out of its cash pile. The results of the arbitration in Singapore against Henkel can also have an effect on the investors, but management has not commented on this matter.
Can It Scale Back to Its Former Glory?
Undoubtedly, it would be a tough transition year for Jyothy Labs, but the company does have some competitive strengths to rely on, such as strong brands, a pan-India distribution channel, manufacturing capabilities, and lack of debt on the balance sheet.
Provided that Exo is able to grab some significant market share in the dishwash liquid space and, at the same time, the other products keep performing steadily well, then Jyothy can slowly mitigate the impact of losing Pril. Nevertheless, this turnaround is not likely to occur in a day. It all depends on execution in new product launches, marketing spends, acquisitions and margin improvements.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post FMCG Stock Down 60% From Its High: Can It Scale Back to Its Former Glory? appeared first on Trade Brains.
Original Article
(Disclaimer – This post is auto-fetched from publicly available RSS feeds. Original source: Tradebrains. All rights belong to the respective publisher.)
